Survival benefits with EPIC in addition to HIPEC for low grade appendiceal neoplasms with pseudomyxoma peritonei: a propensity score matched study [0.03%]
EPIC联合HIPEC治疗阑尾低级别黏膜肿瘤伴假性粘液瘤的生存优势：倾向匹配研究
Raymond Hayler,Kathleen Lockhart,Shoma Barat et al.
Raymond Hayler et al.
Objectives: Appendiceal cancer is a rare malignancy, occurring in roughly 1.2 per 100,000 per year. Low grade appendiceal neoplasams (LAMN) in particular can lead to pseudomyxoma peritonei (PMP), and respond poorly to sys...
Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study [0.03%]
加速康复在完全减瘤手术及腹腔热灌注化疗中实施的病例对照研究
Diane Charleux-Muller,Thibaut Fabacher,Benoit Romain et al.
Diane Charleux-Muller et al.
Objectives: Current recommendations regarding enhanced recovery programs (ERPs) after complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are based on a low level of evidence. The a...
A study of somatic BRCA variants and their putative effect on protein properties in malignant mesothelioma [0.03%]
恶性间皮瘤中BRCA体细胞变异及其对蛋白性质潜在影响的研究
Kritika Krishnamurthy,Kei Shing Oh,Sarah Alghamdi et al.
Kritika Krishnamurthy et al.
Objectives: The aim of this study is to analyze the prevalence of somatic mutations in BRCA1 and BRCA2 in malignant mesothelioma and their putative impact on protein properties. ...
Histological tumor response predicts clinical outcome in patients with colorectal peritoneal metastasis treated with preoperative chemotherapy followed by cytoreduction and HIPEC [0.03%]
新辅助化疗后行腹减瘤及HIPEC治疗的结直肠癌腹膜转移患者其病理缓解程度可预测预后
Isa Valéria Ferreira de Sousa,Joanne M D Lopes,Jorge P M Nogueiro et al.
Isa Valéria Ferreira de Sousa et al.
Objectives: Up to one quarter of the patients with colorectal cancer (CRC) develop peritoneal carcinomatosis (PM). The aims of this retrospective study were to characterize the histological response of the PM of CRC to pr...
Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritonei [0.03%]
伪粘液肉瘤腹膜炎临床和放射学资料汇报最小数据组的确定
Thale D J H Patrick-Brown,Faheez Mohamed,Andrew Thrower et al.
Thale D J H Patrick-Brown et al.
Objectives: Pseudomyxoma peritonei (PMP) is a rare cancer currently affecting over 11,736 patients across Europe. Since PMP is so uncommon, collaboration between scientific centers is key to discovering the mechanisms beh...
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in small bowel adenocarcinoma with peritoneal metastasis: a systematic review [0.03%]
小肠腺癌伴腹膜转移的细胞减灭术(CRS)和腹腔热灌注化疗(HIPEC)：系统性回顾
Vicky Chen,Morgan Jones,Lauren Cohen et al.
Vicky Chen et al.
Objectives: Small bowel adenocarcinoma (SBA) with peritoneal metastasis (PM) is rare and despite treatment with systemic chemotherapy, the prognosis is poor. However, there is emerging evidence that cytoreductive surgery ...
Erector spinae plane blocks for day-case medical thoracoscopy: a pilot clinical study [0.03%]
竖脊肌平面阻滞用于日间医疗胸腔镜检查的初步临床研究
Jamie McPherson,Edward Halvey,Avinash Aujayeb
Jamie McPherson
Objectives: Erector spinae plane (ESP) blocks are a regional anaesthetic technique used for pain relief in thoracic procedures. Our centre has recently begun using ESP blocks pre-medical thoracoscopy for analgesia. ...
Peritoneal regression grading score (PRGS) in peritoneal metastasis: how many biopsies should be examined? [0.03%]
腹膜转移的腹膜退行性分级评分（PRGS）：应该检查多少活检样本？
Wiebke Solass,Christoph Meisner,Florian Kurtz et al.
Wiebke Solass et al.
Objectives: The four-tied peritoneal regression grading score (PRGS) is increasingly used to evaluate the response of peritoneal metastases (PM) to chemotherapy. The minimal number of peritoneal biopsies needed for PRGS d...
Cytologic features of epithelioid gastrointestinal stromal tumor in a pleural effusion. A diagnostic challenge [0.03%]
胸腔积液中上皮样胃肠间质肿瘤的细胞学特征：一个诊断难题
Mariel Valdivia-Mazeira,Carlos Gordillo,Zehra Avan et al.
Mariel Valdivia-Mazeira et al.